These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7512034)

  • 1. Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway?
    Vignaux F; Golstein P
    Eur J Immunol; 1994 Apr; 24(4):923-7. PubMed ID: 7512034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas-based d10S-mediated cytotoxicity requires macromolecular synthesis for effector cell activation but not for target cell death.
    Luciani MF; Golstein P
    Philos Trans R Soc Lond B Biol Sci; 1994 Aug; 345(1313):303-9. PubMed ID: 7531347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine-insensitive partial signaling and multiple roles of Ca2+ in Fas ligand-induced lysis.
    Rogers AM; Thilenius AR; Russell JH
    J Immunol; 1997 Oct; 159(7):3140-7. PubMed ID: 9317111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gld/gld mice are unable to express a functional ligand for Fas.
    Ramsdell F; Seaman MS; Miller RE; Tough TW; Alderson MR; Lynch DH
    Eur J Immunol; 1994 Apr; 24(4):928-33. PubMed ID: 7512035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
    Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
    J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.
    Stalder T; Hahn S; Erb P
    J Immunol; 1994 Feb; 152(3):1127-33. PubMed ID: 7507960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the Fas lytic pathway in cloned CTL.
    Glass A; Walsh CM; Lynch DH; Clark WR
    J Immunol; 1996 May; 156(10):3638-44. PubMed ID: 8621897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
    Moreno MB; Memon SA; Zacharchuk CM
    J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular mechanism of FasL-mediated cytotoxicity by CD4+ Th1 clones.
    el-Khatib M; Stanger BZ; Dogan H; Cui H; Ju ST
    Cell Immunol; 1995 Jul; 163(2):237-44. PubMed ID: 7541726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A.
    Anel A; Buferne M; Boyer C; Schmitt-Verhulst AM; Golstein P
    Eur J Immunol; 1994 Oct; 24(10):2469-76. PubMed ID: 7523141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of murine T cells via the Ly-6C antigen: lack of proliferative response in aberrant T cells from lpr/lpr and gld/gld mice despite high Ly-6C antigen expression.
    Dumont FJ
    J Immunol; 1987 Jun; 138(12):4106-13. PubMed ID: 2438334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
    Bonardelle D; Benihoud K; Kiger N; Bobé P
    J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of Fas/Fas ligand interaction in CD28-independent pathway of allogeneic murine hepatocyte rejection.
    Kawahara T; Kasai S; Yagita H; Sawa M; Kato K; Azuma M; Nakajima A; Okumura K; Futagawa S; Mito M
    Hepatology; 1997 Oct; 26(4):944-8. PubMed ID: 9328317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements for triggering of lysis by cytolytic T lymphocyte clones.
    Lancki DW; Weiss A; Fitch FW
    J Immunol; 1987 Jun; 138(11):3646-53. PubMed ID: 2953785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional expression of Fas (CD95) protein in autoimmune lpr mice.
    Cui H; Ju ST; Sherr DH
    Cell Immunol; 1996 Nov; 174(1):35-41. PubMed ID: 8929452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor.
    Tucek-Szabo CL; Andjelić S; Lacy E; Elkon KB; Nikolić-Zugić J
    J Immunol; 1996 Jan; 156(1):192-200. PubMed ID: 8598462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell lysis of murine renal cancer: multiple signaling pathways for cell death via Fas.
    Sayers TJ; Brooks AD; Seki N; Smyth MJ; Yagita H; Blazar BR; Malyguine AM
    J Leukoc Biol; 2000 Jul; 68(1):81-6. PubMed ID: 10914493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
    Williams NS; Engelhard VH
    J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
    J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.